HIV market barriers affect has got over one in 10 HIV prescriptions with the top brands.
Posted December 14, 2018 by snehaaark
In US, where market barriers affect just over one in 10 HIV prescriptions, the top brand has a significant lead over all other brands.
Feature News
Top Takeaways
Barriers affect just over one in 10 prescriptions: But is it cost, formulary issues or some other barrier combinations that cause the most amount of pain?
Only one brand sees a significant share increase: Four brands gain share thanks to barriers, but the top-gaining brand sees a much bigger bump than the other three.
Eliminating barriers would have limited impact at the top and bottom of the table: The leading brand relies on other brands losing out, but removing barriers wouldn’t have a massive impact on market share for other brands. What does this mean to the overall makeup of the market?
Two brands have a perception problem: Between a quarter and a third of surveyed doctors would not prescribe these brands, leaving other brands to capture market share.
Major HIV Drugs:
Atripla (efavirenz/emtricitabine/tenofovir disoproxil fumarate; Gilead)
Descovy (emtricitabine/tenofovir alafenamide; Gilead)
Genvoya (cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide; Gilead)
Odefsey (emtricitabine/rilpivirine/tenofovir alafenamide; Gilead)
Triumeq (abacavir/dolutegravir/lamivudine; ViiV Healthcare)
Tivicay (dolutegravir; ViiV Healthcare)
Isentress (raltegravir; Merck & Co.)
Edurant (rilpivirine; Janssen Biotech)
Prezista (darunavir; Janssen Biotech)
Reyataz (atazanavir; Bristol-Myers Squibb)
Juluca (dolutegravir/rilpivirine,ViiV Healthcare)
How barriers affect market access:
What brands do doctors prescribe the most?
How many prescriptions do barriers affect?
Which barriers have the biggest impact?
How barriers affect your brand:
How many doctors prescribe your brand? How many don’t, but would consider it?
Why don’t doctors prescribe your brand? What do they prescribe instead?
Which competing brands does your brand take market share from?
For more details visit link: https://www.aarkstore.com/healthcare/926101/market-access-impact-hiv-2018
Category: Healthcare Market Research
Aarkstore Enterprise
+91 9987295242 | [email protected] | aarkstore.com
-- END ---
Share
| Contact Email | [email protected] |
| Issued By | FirstWord Dossier |
| Phone | +919987295242 |
| Business Address | R,3080 Towne Dr Carmel,In 46032 |
| Country | United States |
| Categories | Health |
| Tags | aarkstore market research , global hiv drug market , global market research reports , healthcare market research reports , market research reports , market research reports sample |
| Last Updated | December 14, 2018 |